Company research
Exousia Bio, Inc.
CIK 1939937Updated Sep 26, 2026
SecurityLMMY · OTC · equity
Name history
LAMY · through Jan 15, 2026L A M Y · through Apr 15, 2024
LMMY price & chart
Loading TradingView…
OTC:LMMY on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
Financials
FY 2025 · USDSource
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| ASSETS | |||
| AssetsUSD | 0Source | 27,453Source | 37,044Source |
| Property, Plant and Equipment, NetUSD | 0Source | 4,952Source | 9,986Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 0Source | 9,537Source | 19,203Source |
| Current assets: | |||
| Cash and Cash Equivalents, at Carrying ValueUSD | — | — | 7,855Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 0Source | 11,500Source | — |
| Assets, CurrentUSD | 0Source | 12,964Source | 7,855Source |
| LIABILITIES AND EQUITY | |||
| LiabilitiesUSD | 0Source | 82,348Source | 66,132Source |
| Stockholders’ equity: | |||
| Common Stock, Value, IssuedUSD | 778Source | 778Source | 778Source |
| Additional Paid in CapitalUSD | 30,992Source | 27,492Source | 27,492Source |
| Retained Earnings (Accumulated Deficit)USD | -31,770Source | -83,165Source | -57,358Source |
| Stockholders' Equity Attributable to ParentUSD | 0Source | -54,895Source | -29,088Source |
| Liabilities and EquityUSD | 0Source | 27,453Source | 37,044Source |
| Current liabilities: | |||
| Liabilities, CurrentUSD | 0Source | 14,169Source | 3,610Source |
| Additional Financial Items | |||
| Accrued Liabilities, CurrentUSD | 0Source | 1,211Source | 610Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Cash flows from operating activities: | |||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Changes in operating assets and liabilities: | |||
| Increase (Decrease) in Accounts ReceivableUSD | -11,500Source | 11,500Source | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -4,528Source | -12,484Source | -38,111Source |
| Cash flows from investing activities: | |||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 0Source | 0Source | 0Source |
| Cash flows from financing activities: | |||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 3,500Source | 5,657Source | 35,859Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 0Source | 1,028Source | 7,855Source |
| Supplemental disclosure of cash flow information: | |||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 0Source | 0Source | 0Source |
| Income Taxes Paid, NetUSD | 0Source | 0Source | 0Source |
| Additional Financial Items | |||
| AmortizationUSD | 7,251Source | 9,667Source | 9,667Source |
| DepreciationUSD | 3,775Source | 5,033Source | 5,033Source |
| General and Administrative ExpenseUSD | 28,380Source | 28,076Source | 56,421Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | 51,395Source | -25,807Source | -56,421Source |
| Operating ExpensesUSD | 31,843Source | 28,076Source | — |
| Other Nonoperating Income (Expense)USD | 86,739Source | 436Source | 0Source |
| Proceeds from Issuance of Common StockUSD | 0Source | 0Source | 27,770Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Total RevenueUSD | 3,750Source | 11,500Source | 0Source |
| Cost of Goods and Services Sold | — | — | — |
| Operating Income (Loss)USD | — | — | -56,421Source |
| Other Nonoperating Income (Expense)USD | 86,739Source | 436Source | 0Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 51,395Source | -25,807Source | -56,421Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | 51,395Source | -25,807Source | -56,421Source |
| Earnings Per Share, BasicUSD per share | 0Source | 0Source | 0Source |
| Earnings Per Share, DilutedUSD per share | 0Source | 0Source | 0Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 7,777,000Source | 7,777,000Source | 5,686,257Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 7,777,000Source | 7,777,000Source | 5,686,257Source |
| Additional Financial Items | |||
| General and Administrative ExpenseUSD | 28,380Source | 28,076Source | 56,421Source |
| Gross ProfitUSD | -3,501Source | 1,833Source | 0Source |
| Operating ExpensesUSD | 31,843Source | 28,076Source | — |